P2P review · GLP-1 receptor agonist
Dulaglutide (Trulicity) P2P review prep
GLP-1 receptor agonist. Indications: T2DM
Drug class
GLP-1 receptor agonist
Payer criteria typically applied
- Metformin failure or contraindication
- A1c documentation
Common medical director objections
- Metformin not tried
- Lower-tier GLP-1 (semaglutide) preferred first
Pitfalls to avoid
- Formulary tier requires step therapy
Frequently asked questions
What does the payer typically require for Dulaglutide (Trulicity)?
Metformin failure or contraindication; A1c documentation.
What objections does the medical director typically raise?
Metformin not tried; Lower-tier GLP-1 (semaglutide) preferred first.
What pitfalls should I avoid during the P2P call?
Formulary tier requires step therapy.
Related class drugs
Sources
Prep Dulaglutide (Trulicity) P2Ps faster — try ApprovalHelp free
ApprovalHelp auto-prepares P2P talking points from the patient's chart, surfaces payer-specific objections, and generates the post-call appeal draft. no setup fee.
Get started →Contact: hello@approvalhelp.com